Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1005

1.

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.

EORTC Breast Cancer Cooperative Group.; EORTC Radiotherapy Group., Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Gennaro M, Rouanet P, Avril A, Fentiman IS, Bartelink H, Rutgers EJ.

J Clin Oncol. 2006 Jul 20;24(21):3381-7.

PMID:
16801628
2.

Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.

Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21.

PMID:
16005576
3.

Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience.

Cutuli B, Cohen-Solal-le Nir C, de Lafontan B, Mignotte H, Fichet V, Fay R, Servent V, Giard S, Charra-Brunaud C, Lemanski C, Auvray H, Jacquot S, Charpentier JC.

Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):868-79.

PMID:
12095552
4.

Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.

Donker M, Litière S, Werutsky G, Julien JP, Fentiman IS, Agresti R, Rouanet P, de Lara CT, Bartelink H, Duez N, Rutgers EJ, Bijker N.

J Clin Oncol. 2013 Nov 10;31(32):4054-9. doi: 10.1200/JCO.2013.49.5077.

PMID:
24043739
5.

[Ductal carcinoma in situ of the breast. Analysis of 882 cases].

Cutuli B, Fay R, Cohen-Solal-Le Nir C, De Lafontan B, Mignotte H, Servent V, Giard S, Auvray H, Charra-Brunaud C, Gonzague-Casabianca L, Quetin P.

Presse Med. 2004 Jan 31;33(2):83-9. French.

PMID:
15026697
6.

Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy.

Rodrigues N, Carter D, Dillon D, Parisot N, Choi DH, Haffty BG.

Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1331-5.

PMID:
12459354
7.

259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.

Breast Cancer Res Treat. 2008 Jun;109(3):405-16. Review.

PMID:
17687650
8.

Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.

Solin LJ, McCormick B, Recht A, Haffty BG, Taylor ME, Kuske RR, Bornstein BA, McNeese M, Schultz DJ, Fowble BL, Barrett W, Yeh IT, Kurtz JM, Amalric R, Fourquet A.

Cancer J Sci Am. 1996 May-Jun;2(3):158-65.

PMID:
9166516
9.

Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.

Meijnen P, Oldenburg HS, Peterse JL, Bartelink H, Rutgers EJ.

Ann Surg Oncol. 2008 Jan;15(1):235-43.

PMID:
17987342
10.

[Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].

Fodor J, Mózsa E, Zaka Z, Polgár C, Major T.

Magy Onkol. 2005;49(3):203, 205-8. Hungarian.

11.

Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials.

Viani GA, Stefano EJ, Afonso SL, De Fendi LI, Soares FV, Leon PG, Guimarães FS.

Radiat Oncol. 2007 Aug 2;2:28.

12.

Is radiotherapy needed after adequate local excision of localized DCIS?

Cutuli B.

Int J Fertil Womens Med. 2004 Sep-Oct;49(5):231-6. Review.

PMID:
15633482
13.

Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.

Monteau A, Sigal-Zafrani B, Kirova YM, Fourchotte V, Bollet MA, Vincent-Salomon A, Asselain B, Salmon RJ, Fourquet A.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1021-8. doi: 10.1016/j.ijrobp.2008.12.014.

PMID:
19386441
14.

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.

Julien JP, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P, Avril A, Sylvester R, Mignolet F, Bartelink H, Van Dongen JA.

Lancet. 2000 Feb 12;355(9203):528-33.

PMID:
10683002
15.

The role of radiotherapy in the conservative treatment of ductal carcinoma in situ of the breast.

Polgár C, Kahán Z, Orosz Z, Gábor G, Hadijev J, Cserni G, Kulka J, Jani N, Sulyok Z, Lázár G, Boross G, Diczházi C, Szabó E, László Z, Péntek Z, Major T, Fodor J.

Pathol Oncol Res. 2008 Jun;14(2):179-92. doi: 10.1007/s12253-008-9044-x. Review.

PMID:
18438723
16.

Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.

Solin LJ, Fourquet A, Vicini FA, Haffty B, Taylor M, McCormick B, McNeese M, Pierce LJ, Landmann C, Olivotto IA, Borger J, de La Rochefordiere A, Schultz DJ.

Cancer. 2001 Mar 15;91(6):1090-7.

PMID:
11267953
17.

Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer.

Galper S, Blood E, Gelman R, Abner A, Recht A, Kohli A, Wong JS, Smith D, Bellon J, Connolly J, Schnitt S, Winer E, Silver B, Harris JR.

Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):348-57.

PMID:
15667952
18.

Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.

Sahoo S, Recant WM, Jaskowiak N, Tong L, Heimann R.

Breast J. 2005 Jul-Aug;11(4):242-7.

PMID:
15982389
19.

Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.

Halasz LM, Sreedhara M, Chen YH, Bellon JR, Punglia RS, Wong JS, Harris JR, Brock JE.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e581-6. doi: 10.1016/j.ijrobp.2011.08.015.

PMID:
22208975
20.

Outcomes and factors impacting local recurrence of ductal carcinoma in situ.

Weng EY, Juillard GJ, Parker RG, Chang HR, Gornbein JA.

Cancer. 2000 Apr 1;88(7):1643-9.

PMID:
10738223
Items per page

Supplemental Content

Support Center